Joe Terzo
Papers
1
Total Citations
24
H-Index
1
About
Joe Terzo is a researcher whose work has centered on virology and drug discovery, with a particular focus on hepatitis C virus (HCV) protease inhibition. His most cited contribution, "A Collaborative Screening Program for the Discovery of Inhibitors of HCV NS2/3 cis-Cleaving Protease Activity" (2002), has garnered 24 citations and exemplifies his role in advancing antiviral strategies. This study, part of a collaborative effort, targeted the NS2/3 protease—a critical enzyme in HCV replication—demonstrating a systematic approach to identifying small-molecule inhibitors. Terzo’s work underscores the importance of team-based screening in tackling challenging viral targets, contributing to the broader understanding of HCV biology and therapeutic development. While his citation count reflects a focused impact, his research highlights the value of persistence in early-stage drug discovery, offering insights for students and researchers exploring antiviral mechanisms. Terzo’s legacy lies in his methodical exploration of protease inhibition, a stepping stone for later breakthroughs in HCV treatment.
Research Focus
Key Achievements
Top Papers
- 1